Develops prenatal and oncology tests that detect genetic targets in cell-free DNA.
Jun 2026Revenue $397M/yrExpenses $354M/yr
Reached break-even Oct 2025
Figures by year
When did BillionToOne become profitable?
Its revenue passed its expenses in Oct 2025. In the 12 months to Jun 2026, revenue was $397M and expenses $354M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $305M | $289M | $16.0M |
| Dec 2024 | $153M | $200M | −$47.1M |
| Dec 2023 | $71.7M | $141M | −$69.5M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.